The ability to characterize the pulmonary circulation more fully paved the way for many advances. In the 1950s, Dr David ...

When most people hear the word hypertension, they think of high blood pressure. While not as common as high blood pressure, ...

Winrevair lowered death or transplant risk in adults with PAH functional class 3-4 at high risk of dying; all in study may ...

Advancements and Projections in the Global Pulmonary Arterial Hypertension Market: Insights, Trends, Opportunities, and ...

The Global Pulmonary Arterial Hypertension (PAH) Treatment Market is set for steady growth, with an estimated market size of ...

Winrevair, which treats hypertension from constricted lung arteries, costs $3,700-$6,730 The National University Heart Centre ...

Ferrer is using Pulmonary Hypertension Awareness Month to sound the alarm about the shortcomings of the current pathways for ...